Quaker Houghton · NYSE:KWR
Quaker Houghton — Quaker Chemical — Q3 2026 Earnings Presentation
15 slides from Quaker Houghton's earnings presentation, Oct 29, 2026
Slide 1: Quaker Houghton Third Quarter 2026 Results Investor Conference Call
Quaker Houghton Third Quarter 2026 Results Investor Conference Call
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation contains “forward-looking statements” that fall under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. These statements can be identified by
Slide 3: Non-GAAP financial information
The information in this presentation includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP gross profit, non-GAAP gross margin, taxes on income before equity in net income of a
Slide 4: Speakers
Joe Berquist Chief Executive Officer, President Tom Coler Executive Vice President, Chief Financial Officer Robert T. Traub Senior Vice President, General Counsel & Corporate Secretary John Dalhoff Director, Investor Relations ©2026 Quaker Houghton. All Rights Reserved 4 Speakers
Slide 5: Q3'26 Highlights
Q3’26 Highlights © 2026 Quaker Houghton. All Rights Reserved $545m Net Sales $247m Adjusted EBITDA1 5 $2.39 Non-GAAP Earnings per Diluted Share1 2.3x Leverage Ratio1,2 1 This is a non-GAAP measure, refer to the reconciliations of our non-GAAP measures to their most comparable GAAP measures provided
Slide 6: Financial Snapshot
©2026 Quaker Houghton. All Rights Reserved 6 Financial Snapshot (Unaudited; Dollars in millions, unless otherwise noted) 1 Certain amounts may not calculate due to rounding 2 These are non-GAAP measures. Refer to the reconciliations of our non-GAAP measures to their most comparable GAAP measures pro
Slide 7: Total Company Volume Trend
Sales volumes increased by 3% in Q3’26 compared to Q3’25, primarily due to new business wins across all segments. Sequentially, sales volumes decreased by 2% in Q3’26 compared to Q2’26 Total Company Volume Trend1 (kilograms) 7 ©2026 Quaker Houghton. All Rights Reserved Q1 2024 Q2 2024 Q3 2024 Q4 202
Slide 8: Adjusted EBITDA
©2026 Quaker Houghton. All Rights Reserved 8 Adjusted EBITDA1 (dollars in millions) Generated $90m of adjusted EBITDA in Q3’26, an increase of 8% year-over-year 1 This is a non-GAAP measure, refer to the reconciliations of our non-GAAP measures to their most comparable GAAP measures provided within
Slide 9: Leverage and Liquidity Update
Leverage and Liquidity Update 9 ©2026 Quaker Houghton. All Rights Reserved 1 Leverage ratio, which is a non-GAAP measure, is defined as gross debt minus cash and cash equivalents divided by trailing twelve month adjusted EBITDA. 2 Defined as net debt divided by trailing twelve month adjusted EBITDA,
Slide 10: Appendix: Actual and Non-GAAP Results
Appendix Actual and Non-GAAP Results
Slide 11: Non-GAAP Gross Profit and Operating Income Reconciliation
©2026 Quaker Houghton. All Rights Reserved 11 Non-GAAP Gross Profit and Operating Income Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Three Months Ended September 30, Nine Months Ended September 30, Non-GAAP Operating Income and Margin Reconciliations 2026 2025 2026 2025
Slide 12: Adjusted EBITDA Reconciliation
©2026 Quaker Houghton. All Rights Reserved 12 Adjusted EBITDA Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin Reconciliations: Three Months Ended September 30, Nine Months Ended September 30, 2026 2025 2026 2025 Net income attr
Slide 13: EBITDA and Adjusted EBITDA Reconciliations: Twelve Months Ended December 31
©2026 Quaker Houghton. All Rights Reserved 13 EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin Reconciliations: Twelve Months Ended December 31, 2025 2024 2023 2022 Net income attributable to Quaker Chemical Corporation $ (2,488) $ 116,644 $ 112,748 $ (15,931) Depreciation and amortization 94,402
Slide 14: Non-GAAP EPS Reconciliation
©2026 Quaker Houghton. All Rights Reserved 14 Non-GAAP EPS Reconciliation Three Months Ended September 30, Nine Months Ended September 30, Non-GAAP Earnings per Diluted Share Reconciliations 2026 2025 2026 2025 GAAP earnings (loss) per diluted share attributable to Quaker Chemical Corporation common
Slide 15: Segment Performance
©2026 Quaker Houghton. All Rights Reserved 15 Segment Performance (Unaudited; Dollars in thousands, unless otherwise noted) Three Months Ended September 30, Nine Months Ended September 30, 2026 2025 2026 2025 Net sales Americas $ 254,030 $ 222,787 $ 704,271 $ 657,560 EMEA 152,466 143,900 452,985 413